Cancer Screening: Present Recommendations, the Development of Multi-Cancer Early Development Tests, and the Prospect of Universal Cancer Screening
Open Access
Abstract
Cancer continues to pose a considerable challenge to global health. In the search for innovative strategies to combat this complex enemy, the concept of universal cancer screening has emerged as a promising avenue for early detection and prevention. In contrast to targeted approaches that focus on specific populations or high-risk individuals, universal screening seeks to cast a wide net to detect incipient malignancies in different demographic groups. This paradigm shift in cancer care underscores the importance of comprehensive screening programs that go beyond conventional boundaries. As our understanding of the complex molecular and genetic basis of cancer deepens, the need to develop comprehensive screening methods becomes increasingly apparent. In this article, we look at the rationale and potential benefits of universal cancer screening.Keywords
This publication has 206 references indexed in Scilit:
- Routine Fecal Occult Blood Screening and Colorectal Cancer Mortality in SwedenJAMA Network Open, 2024
- Multitarget Stool RNA Test for Colorectal Cancer ScreeningJAMA, 2023
- New USPSTF Guidelines for Lung Cancer ScreeningJAMA Surgery, 2021
- Screening for Colorectal CancerJAMA, 2021
- Clinical utility of circulating tumor cells: an updateMolecular Oncology, 2020
- Evaluation of circulating tumor cell clusters for pan‐cancer noninvasive diagnostic triagingCancer Cytopathology, 2020
- SST gene hypermethylation acts as a pan‐cancer marker for pancreatic ductal adenocarcinoma and multiple other tumors: toward its use for blood‐based diagnosisMolecular Oncology, 2020
- Screening for Prostate CancerJAMA, 2018
- Regional Variation of Computed Tomographic Imaging in the United States and the Risk of NephrectomyJAMA Internal Medicine, 2018
- Breast Cancer Screening for Women at Average RiskJAMA, 2015